首页 > 最新文献

Journal of Interventional Medicine最新文献

英文 中文
Optimal interventional treatment for liver cancer: HAIC, TACE or iTACE? 肝癌最佳介入治疗:HAIC、TACE还是iTACE?
Q3 Medicine Pub Date : 2023-05-01 DOI: 10.1016/j.jimed.2023.03.001
Naijian Ge , Hongbo Wang , Chengjian He, Xiangdong Wang, Jian Huang, Yefa Yang

Primary liver cancer is a common and lethal malignancy in China. Transcatheter arterial chemoembolization (TACE) is globally recognized as the preferred treatment modality for the non-surgical resection of hepatocellular carcinoma (HCC), while transcatheter arterial infusion (TAI) is another effective interventional treatment for HCC. In recent years, hepatic arterial infusion chemotherapy (HAIC) has gained increasing attention as an application-regulated modality for TAI. Owing to the current debate in the medical community regarding the use of HAIC and TACE for the treatment of HCC, the application of both approaches should be considered at a higher level, with a broader perspective and a more normative aspect. Accordingly, we aimed to define the rational combination of liver cancer TAI/HAIC with TACE as infusion transcatheter chemoembolization (iTACE), which suggests that the two interventions are not superior but lead to a mutually beneficial situation. In this review, we sought to discuss the development, specification, application, challenge and innovation, debate, and union of TAI/HAIC and TACE, and the clinical application and latest research on iTACE. We aimed to introduce new concepts of iTACE and expect new breakthroughs in the treatment of liver cancer owing to the combined use of the two major interventional tools.

原发性肝癌癌症是我国常见的恶性肿瘤。经导管动脉化疗栓塞(TACE)是全球公认的肝细胞癌(HCC)非手术切除的首选治疗方式,而经导管动脉灌注(TAI)是HCC的另一种有效介入治疗方法。近年来,肝动脉灌注化疗(HAIC)作为TAI的一种应用调控模式越来越受到关注。鉴于目前医学界对使用HAIC和TACE治疗HCC的争论,应在更高的层面、更广泛的视角和更规范的方面考虑这两种方法的应用。因此,我们旨在将癌症TAI/HAIC与TACE的合理组合定义为输注经导管化疗栓塞(iTACE),这表明这两种干预并非优越,而是导致互利的情况。在这篇综述中,我们试图讨论TAI/HAIC和TACE的发展、规范、应用、挑战和创新、争论和结合,以及iTACE的临床应用和最新研究。我们的目的是引入iTACE的新概念,并期待由于两种主要介入工具的联合使用,在癌症治疗方面取得新的突破。
{"title":"Optimal interventional treatment for liver cancer: HAIC, TACE or iTACE?","authors":"Naijian Ge ,&nbsp;Hongbo Wang ,&nbsp;Chengjian He,&nbsp;Xiangdong Wang,&nbsp;Jian Huang,&nbsp;Yefa Yang","doi":"10.1016/j.jimed.2023.03.001","DOIUrl":"10.1016/j.jimed.2023.03.001","url":null,"abstract":"<div><p>Primary liver cancer is a common and lethal malignancy in China. Transcatheter arterial chemoembolization (TACE) is globally recognized as the preferred treatment modality for the non-surgical resection of hepatocellular carcinoma (HCC), while transcatheter arterial infusion (TAI) is another effective interventional treatment for HCC. In recent years, hepatic arterial infusion chemotherapy (HAIC) has gained increasing attention as an application-regulated modality for TAI. Owing to the current debate in the medical community regarding the use of HAIC and TACE for the treatment of HCC, the application of both approaches should be considered at a higher level, with a broader perspective and a more normative aspect. Accordingly, we aimed to define the rational combination of liver cancer TAI/HAIC with TACE as infusion transcatheter chemoembolization (iTACE), which suggests that the two interventions are not superior but lead to a mutually beneficial situation. In this review, we sought to discuss the development, specification, application, challenge and innovation, debate, and union of TAI/HAIC and TACE, and the clinical application and latest research on iTACE. We aimed to introduce new concepts of iTACE and expect new breakthroughs in the treatment of liver cancer owing to the combined use of the two major interventional tools.</p></div>","PeriodicalId":33533,"journal":{"name":"Journal of Interventional Medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/3e/22/main.PMC10318322.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9801132","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Initial clinical experience with Xpert-Pro peripheral self-expanding stent system for internal carotid artery dissection: Two case reports expert - pro外周自扩张支架系统治疗颈内动脉夹层的初步临床经验:2例报告
Q3 Medicine Pub Date : 2023-05-01 DOI: 10.1016/j.jimed.2023.04.003
Ning Li , Xinzhao Jiang , Zhora Baghdasaryan , Peng Wang

Background

The standard treatment for internal carotid artery (ICA) dissection is obscure. Current therapeutic strategies include the use of antiplatelet drugs, anticoagulant drugs, intravenous thrombolysis, and endovascular treatment. Endovascular treatment is important in acute internal carotid artery dissection. This study reports two acute internal carotid artery dissection cases that were treated successfully using the Xpert-Pro peripheral self-expanding stent system.

Case summary

The first case was of a 38-year-old male patient with transient speechlessness and paralysis of the right limb in July 2021. Cervical computed tomographic angiography (CTA) showed ICA occlusion on the left side. Digital subtraction angiography (DSA) showed severe stenosis of the C1 segment of the left internal carotid artery with intermural hematoma. The patient subsequently underwent Xpert-Pro peripheral self-expanding stent implantation, and his condition stabilized. The second case was of a 56-year-old male patient with speechlessness and paralysis of the right limb. Cervical CTA showed a dissected left ICA, and DSA showed an occluded left ICA and middle cerebral artery. The patient subsequently underwent stent implantation, and his condition stabilized.

背景:颈内动脉夹层的标准治疗方法尚不明确。目前的治疗策略包括使用抗血小板药物、抗凝药物、静脉溶栓和血管内治疗。血管内治疗是急性颈内动脉夹层的重要治疗方法。本研究报告了两例使用expert - pro外周自扩张支架系统成功治疗的急性颈内动脉夹层病例。首例患者为男性,38岁,于2021年7月出现一过性失语、右肢麻痹。颈椎计算机断层血管造影(CTA)显示左侧ICA闭塞。数字减影血管造影(DSA)显示左侧颈内动脉C1段严重狭窄伴壁间血肿。患者随后行expert - pro外周自扩张支架植入术,病情稳定。第二例为56岁男性患者,伴有右侧肢体瘫痪和失语。颈CTA显示左侧ICA夹层,DSA显示左侧ICA和大脑中动脉闭塞。患者随后接受支架植入,病情稳定。
{"title":"Initial clinical experience with Xpert-Pro peripheral self-expanding stent system for internal carotid artery dissection: Two case reports","authors":"Ning Li ,&nbsp;Xinzhao Jiang ,&nbsp;Zhora Baghdasaryan ,&nbsp;Peng Wang","doi":"10.1016/j.jimed.2023.04.003","DOIUrl":"10.1016/j.jimed.2023.04.003","url":null,"abstract":"<div><h3>Background</h3><p>The standard treatment for internal carotid artery (ICA) dissection is obscure. Current therapeutic strategies include the use of antiplatelet drugs, anticoagulant drugs, intravenous thrombolysis, and endovascular treatment. Endovascular treatment is important in acute internal carotid artery dissection. This study reports two acute internal carotid artery dissection cases that were treated successfully using the Xpert-Pro peripheral self-expanding stent system.</p></div><div><h3>Case summary</h3><p>The first case was of a 38-year-old male patient with transient speechlessness and paralysis of the right limb in July 2021. Cervical computed tomographic angiography (CTA) showed ICA occlusion on the left side. Digital subtraction angiography (DSA) showed severe stenosis of the C1 segment of the left internal carotid artery with intermural hematoma. The patient subsequently underwent Xpert-Pro peripheral self-expanding stent implantation, and his condition stabilized. The second case was of a 56-year-old male patient with speechlessness and paralysis of the right limb. Cervical CTA showed a dissected left ICA, and DSA showed an occluded left ICA and middle cerebral artery. The patient subsequently underwent stent implantation, and his condition stabilized.</p></div>","PeriodicalId":33533,"journal":{"name":"Journal of Interventional Medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/15/90/main.PMC10318317.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9794876","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Expert consensus on emergency procedures for portal hypertension bleeding (2022) 门静脉高压出血急诊程序专家共识(2022)。
Q3 Medicine Pub Date : 2023-02-01 DOI: 10.1016/j.jimed.2022.10.006
Lin Sun , Lin Long , Qing Wang , Hua Xiang

Expert consensus proposes an emergency treatment protocol for portal hypertension bleeding. Herein, the emergency treatment procedures, which include first aid, medical, interventional, and surgical treatments, are described. In addition, the indications, contraindications, operating norms, precautions, and prevention of complications of portal hypertension are described to optimize the first aid process.

专家共识提出了门静脉高压出血的紧急治疗方案。本文描述了紧急治疗程序,包括急救、医疗、介入和外科治疗。此外,还介绍了门静脉高压症的适应症、禁忌症、操作规范、注意事项和并发症的预防,以优化急救流程。
{"title":"Expert consensus on emergency procedures for portal hypertension bleeding (2022)","authors":"Lin Sun ,&nbsp;Lin Long ,&nbsp;Qing Wang ,&nbsp;Hua Xiang","doi":"10.1016/j.jimed.2022.10.006","DOIUrl":"10.1016/j.jimed.2022.10.006","url":null,"abstract":"<div><p>Expert consensus proposes an emergency treatment protocol for portal hypertension bleeding. Herein, the emergency treatment procedures, which include first aid, medical, interventional, and surgical treatments, are described. In addition, the indications, contraindications, operating norms, precautions, and prevention of complications of portal hypertension are described to optimize the first aid process.</p></div>","PeriodicalId":33533,"journal":{"name":"Journal of Interventional Medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/11/5f/main.PMC10167519.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9461403","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy of patient-controlled hydromorphone analgesia in those undergoing uterine fibroid artery embolization via the right radial artery 患者自控氢吗啡酮镇痛对经右桡动脉栓塞子宫肌瘤动脉患者的疗效。
Q3 Medicine Pub Date : 2023-02-01 DOI: 10.1016/j.jimed.2023.01.001
Yanli Wang , Yi Zhao , Miao Xu , Yanling Wang , Songmei Li , Yi Fang , Xinwei Han , Kai Zhang

Objective

To evaluate the efficacy and safety of patient-controlled analgesia (PCA) with hydromorphone as perioperative analgesia during uterine artery embolization (UAE) via the right radial artery.

Patients and methods

A total of 33 patients with uterine fibroids, who underwent UAE at the authors’ hospital between June 2021 and March 2022, were selected. Hydromorphone (10 ​mg) was dispensed into a 100 ​ml PCA pump with normal saline. Pump administration was initiated 15 ​min before the start of the procedure, and the intraoperative dose was adjusted according to patient pain level. A numerical rating scale was used to evaluate pain immediately after embolization, 5 ​min after embolization, at the end of the procedure, and 6, 12, 24, 48, and 72 ​h after the procedure. Side effects were also observed.

Results

Thirty-three patients underwent uterine artery embolization via the right radial artery. Patient pain was well controlled at all time points surveyed, and patients reported satisfaction with analgesia. The median length of hospital stay was 5 days. There were 7 cases of adverse reactions, but no serious side effects were observed.

Conclusion

Patients reported positive experiences with arterial embolization of uterine fibroids via the right radial artery. Hydromorphone PCA effectively controlled pain. The PCA pump is easy to operate, has a low incidence of adverse reactions, and offers economic benefits at the patient and institutional levels.

目的:评价氢吗啡酮用于经右桡动脉子宫动脉栓塞(UAE)围术期镇痛的有效性和安全性。患者和方法:共选择了33名子宫肌瘤患者,他们于2021年6月至2022年3月在作者医院接受了UAE治疗。氢吗啡酮(10​mg)分配到100​ml PCA泵和生理盐水。启动泵给药15​min,并根据患者疼痛程度调整术中剂量。使用数字评定量表评估栓塞后立即疼痛,5​栓塞后分钟,手术结束时,以及6、12、24、48和72​h。还观察到副作用。结果:经右桡动脉栓塞子宫动脉33例。在调查的所有时间点,患者的疼痛都得到了很好的控制,患者对镇痛感到满意。住院时间中位数为5天。有7例不良反应,但没有观察到严重的副作用。结论:患者报告了经右桡动脉栓塞子宫肌瘤的积极经验。氢吗啡酮PCA有效控制疼痛。PCA泵易于操作,不良反应发生率低,并在患者和机构层面提供经济效益。
{"title":"Efficacy of patient-controlled hydromorphone analgesia in those undergoing uterine fibroid artery embolization via the right radial artery","authors":"Yanli Wang ,&nbsp;Yi Zhao ,&nbsp;Miao Xu ,&nbsp;Yanling Wang ,&nbsp;Songmei Li ,&nbsp;Yi Fang ,&nbsp;Xinwei Han ,&nbsp;Kai Zhang","doi":"10.1016/j.jimed.2023.01.001","DOIUrl":"10.1016/j.jimed.2023.01.001","url":null,"abstract":"<div><h3>Objective</h3><p>To evaluate the efficacy and safety of patient-controlled analgesia (PCA) with hydromorphone as perioperative analgesia during uterine artery embolization (UAE) via the right radial artery.</p></div><div><h3>Patients and methods</h3><p>A total of 33 patients with uterine fibroids, who underwent UAE at the authors’ hospital between June 2021 and March 2022, were selected. Hydromorphone (10 ​mg) was dispensed into a 100 ​ml PCA pump with normal saline. Pump administration was initiated 15 ​min before the start of the procedure, and the intraoperative dose was adjusted according to patient pain level. A numerical rating scale was used to evaluate pain immediately after embolization, 5 ​min after embolization, at the end of the procedure, and 6, 12, 24, 48, and 72 ​h after the procedure. Side effects were also observed.</p></div><div><h3>Results</h3><p>Thirty-three patients underwent uterine artery embolization via the right radial artery. Patient pain was well controlled at all time points surveyed, and patients reported satisfaction with analgesia. The median length of hospital stay was 5 days. There were 7 cases of adverse reactions, but no serious side effects were observed.</p></div><div><h3>Conclusion</h3><p>Patients reported positive experiences with arterial embolization of uterine fibroids via the right radial artery. Hydromorphone PCA effectively controlled pain. The PCA pump is easy to operate, has a low incidence of adverse reactions, and offers economic benefits at the patient and institutional levels.</p></div>","PeriodicalId":33533,"journal":{"name":"Journal of Interventional Medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/73/42/main.PMC10167514.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9467635","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploration of risk factors for hemoglobinuria and acute kidney injury following iliofemoral venous mechanical thrombectomy 髂股静脉机械血栓切除术后血红蛋白尿和急性肾损伤的危险因素探讨。
Q3 Medicine Pub Date : 2023-02-01 DOI: 10.1016/j.jimed.2022.10.005
Xinqiang Han , Qingqing Zhang , Fengfei Xia , Yongzhen Zhang , Wenming Wang

Objective

To evaluate the risk factors for hemoglobinuria and acute kidney injury (AKI) after percutaneous mechanical thrombectomy (MT) with or without catheter-directed thrombolysis (CDT) for iliofemoral deep vein thrombosis (IFDVT).

Methods

Patients with IFDVT who had MT with the AngioJet catheter (group A), MT plus CDT (group B), or CDT alone (group C) from January 2016 to March 2020 were retrospectively evaluated. Hemoglobinuria was monitored throughout the treatment course, and postoperative AKI was assessed by comparing the preoperative (baseline) and postoperative serum creatinine (sCr) levels from the electronic medical records of all patients. AKI was defined as an elevation in the sCr level exceeding 26.5 ​μmol/L within 72 ​h after the operation according to the Kidney Disease Improving Global Outcomes criteria.

Results

A total of 493 consecutive patients with IFDVT were reviewed, of which 382 (mean age, 56 ​± ​11 years; 41% of them were females; 97 in group A, 128 in group B, and 157 in group C) were finally analyzed. Macroscopic hemoglobinuria was evident in 44.89% of the patients of the MT groups (101/225, 39 in group A, and 62 in group B), with no significant difference between the groups (P ​= ​0.219), but not in the patients in group C. None of the patients developed AKI (mean sCr difference −2.76 ​± ​13.80 ​μmol/L, range ​= ​−80.20 to 20.60 ​μmol/L) within 72 ​h after surgery.

Conclusions

Rheolytic MT is an independent risk factor for hemoglobinuria. A proper aspiration strategy, hydration, and alkalization following thrombectomy are particularly favorable for preventing AKI.

目的:评价经皮机械血栓切除术(MT)伴或不伴导管导向溶栓治疗髂股深静脉血栓形成(IFDVT)后发生血红蛋白尿和急性肾损伤(AKI)的危险因素,或单独CDT(C组)从2016年1月至2020年3月进行回顾性评估。在整个治疗过程中监测血红蛋白尿,并通过比较所有患者电子医疗记录中的术前(基线)和术后血清肌酐(sCr)水平来评估术后AKI。AKI被定义为sCr水平超过26.5的高程​μmol/L在72内​根据肾脏疾病改善全球结果标准,手术后h。结果:共回顾了493例IFDVT连续患者,其中382例(平均年龄,56岁)​±​11年;其中女性占41%;A组97例,B组128例,C组157例)。MT组有44.89%的患者出现肉眼可见的血红蛋白尿(101/225,A组39,B组62),两组间差异无统计学意义(P​=​0.219),但在C组患者中没有。没有患者出现AKI(平均sCr差异-2.76​±​13.80​μmol/L,范围​=​-80.20至20.60​μmol/L)在72​手术后h。结论:溶血性MT是血红蛋白尿的独立危险因素。血栓切除术后适当的抽吸策略、水合作用和碱化作用对预防AKI特别有利。
{"title":"Exploration of risk factors for hemoglobinuria and acute kidney injury following iliofemoral venous mechanical thrombectomy","authors":"Xinqiang Han ,&nbsp;Qingqing Zhang ,&nbsp;Fengfei Xia ,&nbsp;Yongzhen Zhang ,&nbsp;Wenming Wang","doi":"10.1016/j.jimed.2022.10.005","DOIUrl":"10.1016/j.jimed.2022.10.005","url":null,"abstract":"<div><h3>Objective</h3><p>To evaluate the risk factors for hemoglobinuria and acute kidney injury (AKI) after percutaneous mechanical thrombectomy (MT) with or without catheter-directed thrombolysis (CDT) for iliofemoral deep vein thrombosis (IFDVT).</p></div><div><h3>Methods</h3><p>Patients with IFDVT who had MT with the AngioJet catheter (group A), MT plus CDT (group B), or CDT alone (group C) from January 2016 to March 2020 were retrospectively evaluated. Hemoglobinuria was monitored throughout the treatment course, and postoperative AKI was assessed by comparing the preoperative (baseline) and postoperative serum creatinine (sCr) levels from the electronic medical records of all patients. AKI was defined as an elevation in the sCr level exceeding 26.5 ​μmol/L within 72 ​h after the operation according to the Kidney Disease Improving Global Outcomes criteria.</p></div><div><h3>Results</h3><p>A total of 493 consecutive patients with IFDVT were reviewed, of which 382 (mean age, 56 ​± ​11 years; 41% of them were females; 97 in group A, 128 in group B, and 157 in group C) were finally analyzed. Macroscopic hemoglobinuria was evident in 44.89% of the patients of the MT groups (101/225, 39 in group A, and 62 in group B), with no significant difference between the groups (P ​= ​0.219), but not in the patients in group C. None of the patients developed AKI (mean sCr difference −2.76 ​± ​13.80 ​μmol/L, range ​= ​−80.20 to 20.60 ​μmol/L) within 72 ​h after surgery.</p></div><div><h3>Conclusions</h3><p>Rheolytic MT is an independent risk factor for hemoglobinuria. A proper aspiration strategy, hydration, and alkalization following thrombectomy are particularly favorable for preventing AKI.</p></div>","PeriodicalId":33533,"journal":{"name":"Journal of Interventional Medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10167515/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9467638","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Management of traumatic peripheral artery pseudoaneurysm: A 10-year experience at a single center 外伤性外周动脉假性动脉瘤的治疗:在单一中心的10年经验。
Q3 Medicine Pub Date : 2023-02-01 DOI: 10.1016/j.jimed.2022.10.002
Yingliang Wang , Hai Zheng , Wei Yao , Shuguang Ju , Yaowei Bai , Chaoyang Wang , Chen Zhou , Jiacheng Liu , Chongtu Yang , Songjiang Huang , Tongqiang Li , Yang Chen , Bin Xiong

Purpose

This study aimed to report our 10-year experience with the management of iatrogenic (penetrating trauma) and traumatic (blunt or penetrating trauma) peripheral artery pseudoaneurysms, based on data from a tertiary referral center.

Methods

From January 2012 to December 2021, the medical records of consecutive patients with iatrogenic and traumatic peripheral artery pseudoaneurysms were retrospectively reviewed. Patient demographics, clinical features, imaging data, treatment details, and follow-up results were analyzed.

Results

Sixty-one consecutive patients were included in this study; 48 (79%) were men and 13 (21%) women, with a mean age of 49.4 ​± ​13.4 years (range 24–73 years). There were 42 patients (69%) who underwent open surgery, 18 (29%) undergoing endovascular embolization or stent implantation, and one (2%) undergoing ultrasound-guided thrombin injection. All patients successfully underwent open or interventional treatment. The median follow-up was 46.8 months (2.5–117.9 months), and the overall reintervention rate was 10%. Of these, one (5%) patient in the interventional treatment group and five (12%) patients in the open surgery group underwent reintervention. The overall complication rate was 8%, with complications occurring only in the open surgery group. No deaths occurred in the peri-operative period. No late complications, such as thrombosis or pseudoaneurysm recurrence, were observed.

Conclusion

Peripheral artery pseudoaneurysms arising from iatrogenic or traumatic causes can be effectively treated by both open surgery and interventional procedures in selected patients with acceptable mid- and long-term outcomes.

目的:本研究旨在根据三级转诊中心的数据,报告我们10年来治疗医源性(穿透性创伤)和创伤性(钝性或穿透性损伤)外周动脉假性动脉瘤的经验。方法:回顾性分析2012年1月至2021年12月连续收治的医源性和创伤性外周动脉假性动脉瘤患者的病历。对患者人口统计学、临床特征、影像学数据、治疗细节和随访结果进行分析。结果:61名连续患者被纳入本研究;男性48人(79%),女性13人(21%),平均年龄49.4岁​±​13.4岁(24-73岁)。有42名患者(69%)接受了开放手术,18名患者(29%)接受了血管内栓塞或支架植入,1名患者(2%)接受了超声引导的凝血酶注射。所有患者均成功接受了开放或介入治疗。中位随访时间为46.8个月(2.5-117.9个月),总体再干预率为10%。其中,介入治疗组的一名(5%)患者和开放手术组的五名(12%)患者接受了再介入治疗。总的并发症发生率为8%,并发症仅发生在开放手术组。围手术期无死亡病例。未观察到血栓形成或假性动脉瘤复发等晚期并发症。结论:在选定的患者中,由医源性或创伤性原因引起的外周动脉假性动脉瘤可以通过开放手术和介入治疗得到有效治疗,中长期疗效可接受。
{"title":"Management of traumatic peripheral artery pseudoaneurysm: A 10-year experience at a single center","authors":"Yingliang Wang ,&nbsp;Hai Zheng ,&nbsp;Wei Yao ,&nbsp;Shuguang Ju ,&nbsp;Yaowei Bai ,&nbsp;Chaoyang Wang ,&nbsp;Chen Zhou ,&nbsp;Jiacheng Liu ,&nbsp;Chongtu Yang ,&nbsp;Songjiang Huang ,&nbsp;Tongqiang Li ,&nbsp;Yang Chen ,&nbsp;Bin Xiong","doi":"10.1016/j.jimed.2022.10.002","DOIUrl":"10.1016/j.jimed.2022.10.002","url":null,"abstract":"<div><h3>Purpose</h3><p>This study aimed to report our 10-year experience with the management of iatrogenic (penetrating trauma) and traumatic (blunt or penetrating trauma) peripheral artery pseudoaneurysms, based on data from a tertiary referral center.</p></div><div><h3>Methods</h3><p>From January 2012 to December 2021, the medical records of consecutive patients with iatrogenic and traumatic peripheral artery pseudoaneurysms were retrospectively reviewed. Patient demographics, clinical features, imaging data, treatment details, and follow-up results were analyzed.</p></div><div><h3>Results</h3><p>Sixty-one consecutive patients were included in this study; 48 (79%) were men and 13 (21%) women, with a mean age of 49.4 ​± ​13.4 years (range 24–73 years). There were 42 patients (69%) who underwent open surgery, 18 (29%) undergoing endovascular embolization or stent implantation, and one (2%) undergoing ultrasound-guided thrombin injection. All patients successfully underwent open or interventional treatment. The median follow-up was 46.8 months (2.5–117.9 months), and the overall reintervention rate was 10%. Of these, one (5%) patient in the interventional treatment group and five (12%) patients in the open surgery group underwent reintervention. The overall complication rate was 8%, with complications occurring only in the open surgery group. No deaths occurred in the peri-operative period. No late complications, such as thrombosis or pseudoaneurysm recurrence, were observed.</p></div><div><h3>Conclusion</h3><p>Peripheral artery pseudoaneurysms arising from iatrogenic or traumatic causes can be effectively treated by both open surgery and interventional procedures in selected patients with acceptable mid- and long-term outcomes.</p></div>","PeriodicalId":33533,"journal":{"name":"Journal of Interventional Medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/32/58/main.PMC10167504.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9472954","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The rat eustachian tube: Anatomical, histological, and radiological features 大鼠咽鼓管:解剖学、组织学和放射学特征。
Q3 Medicine Pub Date : 2023-02-01 DOI: 10.1016/j.jimed.2022.12.002
Zhe Wang , Hong-Tao Hu , Nader Bakheet , Sung Hwan Yoon , Jung-Hoon Park , Kun Yung Kim , Jae Yong Jeon , Woo Seok Kang , Ye Ree Kim , Jorge E. Lopera , Hong Ju Park , Ho-Young Song

Purpose

This study investigated the anatomical and histological characteristics of the rat Eustachian tube (E-tube) and the feasibility of Eustachian tubography in a rat model.

Materials and methods

Fifteen male Wistar rats were used in this study, and the bilateral E-tubes of each rat were examined. Ten E-tubes were used for anatomical studies, another ten for histological analysis, and the other ten for Eustachian tubography. Five rats were euthanized and decapitated, and ten E-tubes were dissected to describe the anatomy of the E-tube. Ten E-tube specimens obtained from five other rats were sectioned to investigate E-tube histology. Eustachian tubography was performed on the bilateral E-tubes of the other five rats using the trans-tympanic approach.

Results

The rat E-tubes consisted of bony and membranous parts. Cartilage and bone tissue covered only the bony part. The E-tubes’ mean diameter and overall length were 2.97 ​mm and 4.96 ​mm, respectively. The tympanic orifices’ mean diameter was 1.21 ​mm. The epithelium of E-tubes was mainly composed of pseudostratified ciliated and goblet cells. Eustachian tubography was successfully performed on both sides of the E-tube for each rat. The technical success rate was 100%, the average running time was 4.9 ​min, and no procedure-related complications occurred. On tubography images, the E-tube, tympanic cavity, and nasopharynx could be identified because of the visualization of bony landmarks.

Conclusion

In this study, we described the anatomical and histological features of rat E-tubes. With the aid of these findings, E-tube angiography was successfully performed using a transtympanic approach. These results will facilitate further investigation of E-tube dysfunction.

目的:研究大鼠咽鼓管(E管)的解剖和组织学特征,以及在大鼠模型中进行咽鼓管造影的可行性。材料与方法:本研究选用15只雄性Wistar大鼠,对每只大鼠的双侧电子管进行检查。10根E管用于解剖研究,另外10根用于组织学分析,另外10支用于咽鼓管造影。对5只大鼠实施安乐死并斩首,解剖10根电子管以描述电子管的解剖结构。从另外5只大鼠身上取10个电子管标本进行切片,以研究电子管组织学。采用经鼓室入路对其他5只大鼠的双侧E管进行咽鼓管造影。结果:大鼠电子管由骨和膜两部分组成。软骨和骨组织仅覆盖骨部分。E-管的平均直径和总长度为2.97​mm和4.96​mm。鼓室口的平均直径为1.21​上皮细胞主要由假复层纤毛细胞和杯状细胞组成。在每只大鼠的E管两侧成功地进行了咽鼓管造影。技术成功率100%,平均运行时间4.9​min,未发生与手术相关的并发症。在管造影图像上,由于骨标志的可视化,可以识别E管、鼓室和鼻咽。结论:在本研究中,我们描述了大鼠电子管的解剖和组织学特征。在这些发现的帮助下,使用经鼓室入路成功地进行了E管血管造影术。这些结果将有助于进一步研究电子管功能障碍。
{"title":"The rat eustachian tube: Anatomical, histological, and radiological features","authors":"Zhe Wang ,&nbsp;Hong-Tao Hu ,&nbsp;Nader Bakheet ,&nbsp;Sung Hwan Yoon ,&nbsp;Jung-Hoon Park ,&nbsp;Kun Yung Kim ,&nbsp;Jae Yong Jeon ,&nbsp;Woo Seok Kang ,&nbsp;Ye Ree Kim ,&nbsp;Jorge E. Lopera ,&nbsp;Hong Ju Park ,&nbsp;Ho-Young Song","doi":"10.1016/j.jimed.2022.12.002","DOIUrl":"10.1016/j.jimed.2022.12.002","url":null,"abstract":"<div><h3>Purpose</h3><p>This study investigated the anatomical and histological characteristics of the rat Eustachian tube (E-tube) and the feasibility of Eustachian tubography in a rat model.</p></div><div><h3>Materials and methods</h3><p>Fifteen male Wistar rats were used in this study, and the bilateral E-tubes of each rat were examined. Ten E-tubes were used for anatomical studies, another ten for histological analysis, and the other ten for Eustachian tubography. Five rats were euthanized and decapitated, and ten E-tubes were dissected to describe the anatomy of the E-tube. Ten E-tube specimens obtained from five other rats were sectioned to investigate E-tube histology. Eustachian tubography was performed on the bilateral E-tubes of the other five rats using the <em>trans</em>-tympanic approach.</p></div><div><h3>Results</h3><p>The rat E-tubes consisted of bony and membranous parts. Cartilage and bone tissue covered only the bony part. The E-tubes’ mean diameter and overall length were 2.97 ​mm and 4.96 ​mm, respectively. The tympanic orifices’ mean diameter was 1.21 ​mm. The epithelium of E-tubes was mainly composed of pseudostratified ciliated and goblet cells. Eustachian tubography was successfully performed on both sides of the E-tube for each rat. The technical success rate was 100%, the average running time was 4.9 ​min, and no procedure-related complications occurred. On tubography images, the E-tube, tympanic cavity, and nasopharynx could be identified because of the visualization of bony landmarks.</p></div><div><h3>Conclusion</h3><p>In this study, we described the anatomical and histological features of rat E-tubes. With the aid of these findings, E-tube angiography was successfully performed using a transtympanic approach. These results will facilitate further investigation of E-tube dysfunction.</p></div>","PeriodicalId":33533,"journal":{"name":"Journal of Interventional Medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/24/eb/main.PMC10167518.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9467640","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Balloon-occluded retrograde transvenous obliteration for treatment of congenital intrahepatic portosystemic venous shunt: A case report 球囊闭塞逆行经静脉闭塞术治疗先天性肝内门体静脉分流术一例报告。
Q3 Medicine Pub Date : 2023-02-01 DOI: 10.1016/j.jimed.2022.12.001
Shenggan Lin , Zhenyu Xu , Zhuoyang Fan , Wei Zhang , Guowei Yang , Sheng Qian , Rong Liu

Congenital intrahepatic portosystemic venous shunt (CPSVS), a rare vascular malformation, has been described in both children and adults and can lead to severe neurophysiological complications. However, a standard therapeutic protocol for CPSVS has not been elucidated. With the advantage of minimally invasive techniques, transcatheter embolization has been used to treat CPSVS. The condition is challenging to manage, especially in patients with large or multiple shunts, through which rapid blood flow can cause ectopic embolism. Here, we describe a case of CPSVS with a large shunt that was successfully treated with balloon-occluded retrograde transvenous obliteration with interlocking detachable coils.

先天性肝内门体静脉分流术(CPSVS)是一种罕见的血管畸形,在儿童和成人中都有报道,可导致严重的神经生理学并发症。然而,CPSVS的标准治疗方案尚未阐明。利用微创技术的优势,经导管栓塞已被用于治疗CPSVS。这种情况很难控制,尤其是在有大分流或多分流的患者中,快速的血液流动会导致异位栓塞。在此,我们描述了一例具有大分流的CPSVS,该病例通过带互锁可拆卸线圈的球囊闭塞逆行经静脉闭塞术成功治疗。
{"title":"Balloon-occluded retrograde transvenous obliteration for treatment of congenital intrahepatic portosystemic venous shunt: A case report","authors":"Shenggan Lin ,&nbsp;Zhenyu Xu ,&nbsp;Zhuoyang Fan ,&nbsp;Wei Zhang ,&nbsp;Guowei Yang ,&nbsp;Sheng Qian ,&nbsp;Rong Liu","doi":"10.1016/j.jimed.2022.12.001","DOIUrl":"10.1016/j.jimed.2022.12.001","url":null,"abstract":"<div><p>Congenital intrahepatic portosystemic venous shunt (CPSVS), a rare vascular malformation, has been described in both children and adults and can lead to severe neurophysiological complications. However, a standard therapeutic protocol for CPSVS has not been elucidated. With the advantage of minimally invasive techniques, transcatheter embolization has been used to treat CPSVS. The condition is challenging to manage, especially in patients with large or multiple shunts, through which rapid blood flow can cause ectopic embolism. Here, we describe a case of CPSVS with a large shunt that was successfully treated with balloon-occluded retrograde transvenous obliteration with interlocking detachable coils.</p></div>","PeriodicalId":33533,"journal":{"name":"Journal of Interventional Medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/40/2e/main.PMC10167510.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9467641","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Irreversible electroporation of the pancreas – A decade on 胰腺不可逆电穿孔——十年过去了。
Q3 Medicine Pub Date : 2023-02-01 DOI: 10.1016/j.jimed.2022.10.001
Daniel Yuxuan Ong, Guo Yuan How, Uei Pua

Irreversible electroporation (IRE) employs the use of an electric field to cause irreversible permeability of the cell membrane, inducing apoptosis. The use of IRE for locally advanced pancreatic cancer (LAPC) was first described in 2012. The crucial advantage of IRE compared with other devices employing thermal ablation is the safety around vital structures such as vessels and ducts. This makes it an attractive option for use in the pancreas due to the close proximity of multiple major vascular structures, biliary ducts, and adjacent gastrointestinal organs. Over the past decade, IRE has established itself as a useful treatment adjunct and may soon become the standard of care, particularly for LAPC. This article will explore the current evidence and provide a concise summary of pertinent issues, including patient selection, preoperative management, clinical outcomes, radiological response and future prospects of IRE in pancreatic cancer.

不可逆电穿孔(IRE)利用电场引起细胞膜的不可逆渗透性,诱导细胞凋亡。IRE用于局部晚期癌症(LAPC)于2012年首次被描述。与采用热消融的其他设备相比,IRE的关键优势在于血管和导管等重要结构周围的安全性。由于多个主要血管结构、胆管和邻近的胃肠道器官非常接近,这使其成为胰腺中使用的一个有吸引力的选择。在过去的十年里,IRE已经成为一种有用的治疗辅助手段,并可能很快成为护理标准,尤其是LAPC。本文将探讨目前的证据,并对相关问题进行简要总结,包括患者选择、术前管理、临床结果、放射性反应以及IRE在癌症中的未来前景。
{"title":"Irreversible electroporation of the pancreas – A decade on","authors":"Daniel Yuxuan Ong,&nbsp;Guo Yuan How,&nbsp;Uei Pua","doi":"10.1016/j.jimed.2022.10.001","DOIUrl":"10.1016/j.jimed.2022.10.001","url":null,"abstract":"<div><p>Irreversible electroporation (IRE) employs the use of an electric field to cause irreversible permeability of the cell membrane, inducing apoptosis. The use of IRE for locally advanced pancreatic cancer (LAPC) was first described in 2012. The crucial advantage of IRE compared with other devices employing thermal ablation is the safety around vital structures such as vessels and ducts. This makes it an attractive option for use in the pancreas due to the close proximity of multiple major vascular structures, biliary ducts, and adjacent gastrointestinal organs. Over the past decade, IRE has established itself as a useful treatment adjunct and may soon become the standard of care, particularly for LAPC. This article will explore the current evidence and provide a concise summary of pertinent issues, including patient selection, preoperative management, clinical outcomes, radiological response and future prospects of IRE in pancreatic cancer.</p></div>","PeriodicalId":33533,"journal":{"name":"Journal of Interventional Medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/5c/32/main.PMC10167507.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9467642","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Percutaneous closure of gastrorenal shunt as adjunctive therapy for esophageal carcinoma 经皮胃肾分流术辅助治疗食管癌。
Q3 Medicine Pub Date : 2023-02-01 DOI: 10.1016/j.jimed.2023.01.002
Yanlin Li , Simon Ying-Kit Law , Ka-On Lam , Anthony Wing-Ip Lo

The embolization of gastric varices is an established technique for acute bleeding in patients with portal hypertension. Here, we report an attempt to embolize a gastrorenal shunt to facilitate esophagectomy in a patient with an esophageal malignancy. To our knowledge, this is the first case in the literature to highlight the role of interventional medicine in the treatment of patients with esophageal malignancy.

胃静脉曲张栓塞是治疗门静脉高压患者急性出血的一种成熟技术。在这里,我们报告了一个尝试栓塞胃肾分流,以促进食管癌患者的食管切除术。据我们所知,这是文献中第一个强调介入医学在治疗食管恶性肿瘤患者中的作用的病例。
{"title":"Percutaneous closure of gastrorenal shunt as adjunctive therapy for esophageal carcinoma","authors":"Yanlin Li ,&nbsp;Simon Ying-Kit Law ,&nbsp;Ka-On Lam ,&nbsp;Anthony Wing-Ip Lo","doi":"10.1016/j.jimed.2023.01.002","DOIUrl":"10.1016/j.jimed.2023.01.002","url":null,"abstract":"<div><p>The embolization of gastric varices is an established technique for acute bleeding in patients with portal hypertension. Here, we report an attempt to embolize a gastrorenal shunt to facilitate esophagectomy in a patient with an esophageal malignancy. To our knowledge, this is the first case in the literature to highlight the role of interventional medicine in the treatment of patients with esophageal malignancy.</p></div>","PeriodicalId":33533,"journal":{"name":"Journal of Interventional Medicine","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/e7/bc/main.PMC10167493.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9472952","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Interventional Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1